- Home
- SBCF vs AMPH Comparison
SBCF vs AMPH Comparison
Compare SBCF & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBCF
- AMPH
- Stock Information
- Founded
- SBCF 1926
- AMPH 1996
- Country
- SBCF United States
- AMPH United States
- Employees
- SBCF N/A
- AMPH N/A
- Industry
- SBCF Major Banks
- AMPH Biotechnology: Pharmaceutical Preparations
- Sector
- SBCF Finance
- AMPH Health Care
- Exchange
- SBCF Nasdaq
- AMPH Nasdaq
- Market Cap
- SBCF 2.5B
- AMPH 2.5B
- IPO Year
- SBCF N/A
- AMPH 2014
- Fundamental
- Price
- SBCF $28.22
- AMPH $40.85
- Analyst Decision
- SBCF Hold
- AMPH Buy
- Analyst Count
- SBCF 5
- AMPH 4
- Target Price
- SBCF $28.10
- AMPH $60.33
- AVG Volume (30 Days)
- SBCF 327.9K
- AMPH 458.4K
- Earning Date
- SBCF 01-23-2025
- AMPH 11-06-2024
- Dividend Yield
- SBCF 2.55%
- AMPH N/A
- EPS Growth
- SBCF 10.93
- AMPH 17.38
- EPS
- SBCF 1.36
- AMPH 3.01
- Revenue
- SBCF $494,135,000.00
- AMPH $723,549,000.00
- Revenue This Year
- SBCF N/A
- AMPH $16.86
- Revenue Next Year
- SBCF $8.20
- AMPH $10.07
- P/E Ratio
- SBCF $20.76
- AMPH $13.58
- Revenue Growth
- SBCF N/A
- AMPH 20.33
- 52 Week Low
- SBCF $21.90
- AMPH $36.56
- 52 Week High
- SBCF $31.68
- AMPH $65.92
- Technical
- Relative Strength Index (RSI)
- SBCF 39.69
- AMPH 31.08
- Support Level
- SBCF $28.53
- AMPH $43.34
- Resistance Level
- SBCF $30.21
- AMPH $45.39
- Average True Range (ATR)
- SBCF 0.68
- AMPH 1.31
- MACD
- SBCF -0.26
- AMPH -0.23
- Stochastic Oscillator
- SBCF 1.17
- AMPH 8.36
About SBCF Seacoast Banking Corporation of Florida
Seacoast Banking Corp of Florida is a holding company for Seacoast National Bank. The Company provides integrated financial services including commercial and consumer banking, wealth management, and mortgage and insurance services to customers across Florida, and through mobile and online banking solutions. In addition, it provides services such as treasury management, brokerage, and credit facilities.
About AMPH Amphastar Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.